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Oral biofilms exposure to chlorhexidine results in altered
microbial composition and metabolic profile
Ioanna Chatzigiannidou 1, Wim Teughels2, Tom Van de Wiele1 and Nico Boon1✉
Oral diseases (e.g., dental caries, periodontitis) are developed when the healthy oral microbiome is imbalanced allowing the
increase of pathobiont strains. Common practice to prevent or treat such diseases is the use of antiseptics, like chlorhexidine.
However, the impact of these antiseptics on the composition and metabolic activity of the oral microbiome is poorly addressed.
Using two types of oral biofilms—a 14-species community (more controllable) and human tongue microbiota (more representative)
—the impact of short-term chlorhexidine exposure was explored in-depth. In both models, oral biofilms treated with chlorhexidine
exhibited a pattern of inactivation (>3 log units) and fast regrowth to the initial bacterial concentrations. Moreover, the
chlorhexidine treatment induced profound shifts in microbiota composition and metabolic activity. In some cases, disease
associated traits were increased (such as higher abundance of pathobiont strains or shift in high lactate production). Our results
highlight the need for alternative treatments that selectively target the disease-associated bacteria in the biofilm without targeting
the commensal microorganisms.
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INTRODUCTION
The oral microbiome is one of the most diverse microbial
communities that inhabit the human body1. More than 700
bacterial taxa have been identified to date which inhabit different
niches in the oral cavity by forming biofilms on surfaces such as
the teeth, the gingiva or the tongue (www.homd.org). The oral
microbiome is in continuous interaction with environmental
factors and its host. Under homeostatic conditions, the oral
microbiome is stable and in symbiosis with its host2,3. However
environmental perturbations can lead to a shift into dysbiotic
biofilms which can be a causative factor of oral diseases, such as
caries and periodontitis4,5.
Control of the oral microbiome, prevention and treatment of
oral diseases is often achieved with the help of antimicrobials,
such as antibiotics and antiseptics. The use of antimicrobials aims
at decreasing the total microbial load to tackle the disease. One of
the most common antiseptics used in oral health care is
chlorhexidine (CHX), a bactericidal agent. CHX has a broad
spectrum efficacy and acts by interfering with the cytoplasmic
or inner bacterial wall once it has successfully crossed the outside
membrane6. CHX is commonly added in treatment products at a
concentration of 0.12 or 0.2%. Both concentrations are well above
the minimum inhibitory concentration (MIC) of tested oral strains7.
Yet, such MIC tests expose the microorganisms to a constant
concentration of the biocide. Although this approach is a good
proxy for systemic treatment, it is not representative of a topical
treatment such as a mouth rinse application. In reality the contact
time between the bacteria and the antiseptic is between 60 and
90 s during oral treatment. Moreover in the case of oral diseases,
the target is a polymicrobial biofilm and bacteria in biofilms
exhibit increased tolerance to antimicrobials compared to
planktonic bacteria7. Finally, the biofilm architecture can greatly
influence the outcome of the treatment. The outside layers of the
biofilm are more susceptible to the antiseptic compared to the
inner layers8.
All the above highlight the need for adequate and representa-
tive models to study oral biofilms and their response to current or
future treatments. These models need to capture the complexity
of the biofilm communities but at the same time need to offer
controllability and reproducibility. In the field of oral microbiology,
synthetic communities consisting of two to six key oral strains
have been extensively used to study the interactions between oral
microorganisms and their response to external stimuli9–14. These
simpler synthetic communities allow for a well-controlled system
with known players. Their inter-species interactions can be more
easily studied and modeled15. Furthermore, species concentra-
tions can be determined accurately. On the opposite side of the
experimental spectrum saliva or plaque samples have been used
to grow poly-microbial biofilms in vitro16,17. These more complex
communities better capture the diversity of an in vivo oral biofilm
and the interactions between the oral microorganisms. It is a step
closer to a more realistic model. Yet, the increased complexity of
these systems leads to reduced controllability and require more
elaborate methods to track the community response and
dynamics. As a result, studies assessing the effect of antiseptics
on in vitro biofilms from saliva or plaque origin have primarily
focused on microscopic techniques8,18. Such an approach studies
the response of a biofilm as one unit and does not examine the
community composition. Only few studies have tried to resolve
the above by using amplicon sequencing to track community
shifts19. However, the outcome of the treatment might be greatly
influenced by the composition of the surviving community,
making it very important to identify it while studying the effect
of the antimicrobial stress on the polymicrobial biofilm.
The aim of the present study was to evaluate the impact of
antiseptic treatment on in vitro oral biofilms. Previous studies have
shown that mouthwash rinsing, even when applied consecutively
for many days, had only a temporal effect20. We hypothesized that
the treatment would not only affect the living cells concentration
but also the composition and metabolic activity of the surviving
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community, and that consecutive exposures could enhance this
phenomenon. We used two different microbial communities to
mimic the polymicrobial oral biofilm: (i) a 14-strain biofilm and (ii)
a tongue swab derived microbiota biofilm. The biofilms were
exposed for a short (5 min) period to 0.12% CHX every 24 h to
simulate the oral care procedure and we dynamically monitored
the cell viability, community composition, and metabolic activity.
RESULTS
A dynamic in vitro model was used to mimic oral biofilms and
study their response to antiseptic stress. A 14-species synthetic
community or a tongue swab from four subjects was used as an
inoculum and the response to CHX was evaluated in terms of
microbial survival and regrowth, community composition, and
metabolic activity.
CHX leads to initial drop in biofilm bacterial cell concentration
followed by quick recovery
To test the effect of the antiseptic treatment on cell viability,
in vitro oral biofilms were treated for 5 min with 0.12% CHX during
three consecutive days. Microbial survival was determined by
means of flow cytometry and SGPI (viability) staining. The cells
were separated in three clusters based on their flow cytometric
profile: intact, damaged, and dead.
The initial concentration of intact cells in the 14-species biofilms
was ~107 cells/cm2. Control biofilms that were not exposed to CHX
exhibited a constant growth over time to a final concentration of
1011 intact cells/cm2 at the end of the experiment. In contrast, the
first short exposure to CHX resulted in a large decrease of intact
cells with three log units (to 104 cells/cm2), yet without completely
inactivating the biofilm (Fig. 1a). As expected, an increase in
damaged and dead cells was observed after the treatment. The
intact cell concentration remained stable for the following 24 and
48 h despite the two additional CHX treatments. At 72 h, after
three consecutive days of short CHX exposures, however, the
bacterial concentration sharply rose to 107 cells/cm2 (similar to the
concentration at 0 h) (Fig. 1a). The more complex tongue-swab
derived biofilms displayed a similar pattern of inactivation and
regrowth (Fig. 1b). However their regrowth response was even
faster and took already place after 24 h. More in detail, the initial
intact cell concentration was 106 cells/cm2 and dropped to 104
cells/cm2 immediately after exposure to CHX. Yet, the following
24 h of incubation displayed a 2 log regrowth. The following CHX
exposures at 48 and 72 h showed similar patterns: a drop in intact
cell concentration immediately after CHX treatment, followed by a
rapid regrowth in the subsequent incubation period, eventually
bringing back the intact cell concentration to the original value of
107 cells/cm2. This pattern was consistent for all incubations with
human derived oral biofilms. As expected, the dynamics of
damaged and dead cell concentrations were the opposite of those
from the intact cells.
Biofilm composition shift after CHX treatment
We hypothesized that the antiseptic treatment alters the microbial
composition of the biofilm, as it is already known that suscept-
ibility to CHX is strain dependent. To determine how the
composition changed over time, the abundances of the different
taxa were measured either by means of qPCR (for the 14 strain-
biofilm) or by 16S rRNA gene amplicon sequencing (for the
tongue microbiota derived biofilms).
Non-treated 14 strains biofilms were highly dominated by
Veillonella parvula (99% relative abundance, Fig. 2). In contrast,
CHX exposure had a big impact on community composition as V.
parvula relative abundance rapidly decreased to >5%, while
Streptococcus gordonii showed a big increase in abundance
reaching 94% (±0.08) of the total biofilm at 72 h. The six
pathobionts (P. gingivalis, P. intermedia, A. actinomycontaminants,
Fig. 1 Biofilms exhibited a pattern of kill and regrowth after treatment with 0.12% CHX. Concentrations of live, damaged, and dead cells
for a. 14-species biofilms. Points are the average of four replicates and error bars represent the standard deviation. b For tongue deriving
microbiota biofilm from four individuals (donors). The red line is the concentration of CHX treated biofilms, purple/blue for the non-treated
control biofilms. The vertical red lines represent the points of treatment.
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F. nucleatum, S. mutans, and S. sobrinus) were present at 3–4 log
concentrations lower in the biofilms compared to the more
dominant strains (A. actinomycontaminants <104 cells/cm2 while P.
gingivalis, P. intermedia, F. nucleatum, S. mutans, and S. sobrinus
were <103 cells/cm2). However, these concentrations were
unaffected by CHX and thus remained stable over the course of
the treatment.
16S rRNA gene amplicon sequence analysis revealed the initial
composition of the tongue-swab derived biofilms to be donor-
dependent (Fig. 3). This inter-individual difference became less
clear under control conditions as β-diversity of mature biofilms
dropped over time with samples clustering together in non-metric
multidimensional scaling (NMDS) ordination plots based on
Bray–Curtis dissimilarities (Fig. 3). In sharp contrast, tongue-swab
derived biofilms exposed to CHX were diverging from each other
over time: a clear donor-dependent effect was observed.
At baseline all tongue microbiota derived biofilms were
dominated by Veillonella and Streptococcus, 84–97% were
classified as Veillonellaceae and Streptococcaceae (Fig. 4). Over
the course of the treatment donor-dependent changes were
observed in the most abundant taxa. Donor 1-derived biofilms
exhibited a small decrease in relative abundances of Veillonella.
Donor 2-biofilm displayed a large shift in the composition after the
first CHX treatment with an increase in the relative abundance of
the genus Granulicatella after the first two treatments. Relative
abundances of Fusobacterium, Haemophilus and Solobacterium
increased during the course of treatment in donor 3-biofilm.
Finally, donor 4-biofilm exhibited the most profound community
shift. The composition shifted towards a Fusobacterium mono-
dominance with this genus accounting for more than 90% of the
total community.
Metabolic activity shifted after CHX treatment reflecting the
community shift
To investigate the effect of antiseptic stress on the metabolic
activity of the community, the ability to produce or consume
organic acids was evaluated. The concentration of the lactate,
acetate, propionate, formate and butyrate on surrounding
medium was measured every 24 h.
Non-treated 14-strains biofilms produced propionate (18.96 ±
0.6 mM/day), acetate (13.49 ± 0.19 mM/day) and formate (2.83 ±
0.68mM/day) after the first 24 h (Fig. 5). The relative production of
organic acids remained constant over time in maturing (non-
treated) biofilms. In contrast, total organic acid production by
CHX-treated biofilms greatly decreased to 4.76 ± 0.36 mM/day
after the first exposure to antiseptics, compared to non-treated
biofilms, which produced 43.15 ± 0.33mM/day. After the initial
decrease, total organic acid production recovered but with a
different composition, shifting to a high production of lactate
(23.1 ± 1.00 mM).
Non-treated in vitro tongue microbiota biofilms produced
acetate (25.35 ± 1.34mM/day), propionate (10.24 ± 1.00 mM/day)
and lower concentrations of formate (3.01 ± 2.4 mM/day) and
butyrate (2.96 ± 2.87 mM/day) (total 49.84 ± 3.2 mM/day). Total
production increased over time (69.06 ± 11.38 mM/day) as well as
the relative concentration of butyrate (accounting for 14–23%).
Small differences were observed between donors. On the other
hand, CHX-treated samples produced much lower concentrations
of organic acids (8.03 ± 5.62 mM/day). Notably the donor effect
was again obvious. For donor 1 and 2 relative production did not
change with acetate and propionate being the organic acids
produced at higher concentrations. However, in donor 4-biofilm a
higher production of butyrate (+1.5 mM/day compared to the
other donors) was observed. These results correspond with the
community composition shift and the high relative abundances of
Fusobacterium in the same biofilm.
DISCUSSION
Oral biofilms are polymicrobial communities with a vital role in
oral and systemic health. Oral care commonly includes the use of
wide spectrum antimicrobials (i.e., chlorhexidine). However, these
non-targeted treatments can have a big impact on the innate
commensal microbial community. In fact, previous studies suggest
that antiseptic stress affects oral biofilm composition and
metabolic activity19. Meanwhile the long-term effect and dynamic
response from the oral biofilms to antiseptics is poorly under-
stood. In this study we investigated the response of in vitro oral
biofilms to consecutive treatments with a wide spectrum
antiseptic, i.e., CHX. We evaluated the impact from short daily
CHX exposures on microbiota composition and activity with two
model systems for oral biofilms: (i) a biofilm derived from a
synthetic community composed of 14 commensal and pathobiont
oral strains, being more controllable because of its defined
composition and (ii) a set of biofilms derived from tongue swab
microbiota from healthy individuals, being a closer proxy to the
complexity of the in vivo microbiota. Although moderate model-
dependent differences in the biofilm response to CHX exposure
were noted, the overall trend of CHX affecting community
composition and functionality was consistent in both model
systems.
Simulating a mouthwash procedure, short daily exposures to
0.12% CHX exhibited a repeated pattern of inactivation and rapid
regrowth in both biofilm types. Although chlorhexidine exhibits a
high substantivity which means that the antimicrobial action will
continue longer than the actual rinse21, our findings show CHX to
only have a temporal effect on oral bacterial biofilms which is
supported by both in vivo and in vitro previous studies18,22. These
results indicate that oral antiseptics will fall short of keeping
microbial numbers under control and are thus ineffective in
maintaining oral hygiene. Moreover, as broad-spectrum antisep-
tics such as CHX also affect the endogenous oral microbiota, there
is an increased risk that microbial dysbiosis in the oral cavity will
occur resulting in the development of oral diseases. Indeed, our
results confirm that the community composition from both
Fig. 2 The bacterial composition of the 14-strains biofilms over
the course of treatment. Relative abundance of the individual
strains in 14-strain biofilms every 24 h and before the next CHX
treatment. The percentages are the average of four replicates.
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synthetic as natural oral biofilms are drastically altered upon
repeated CHX exposure. The 14 species-biofilms displayed
profound shifts from a V. parvula dominated community (99%)
to a Streptococcus dominated community, more specifically
Streptococcus gordonii (98%) upon CHX treatment. The higher
tolerance of S. gordonii to CHX, as exhibited by a CHX
susceptibility test (MIC), may explain this result (Supplementary
Table 2). Veillonella species are common colonizers of the oral
cavity and are able to produce propionate from lactate23, which is
typically produced by Streptococcus species. It was therefore not a
surprise that the observed phylogenetic shifts coincided with
drastic changes in metabolite profiles. Untreated biofilms mainly
produced propionate (23.3 mM) while CHX exposed biofilms
mainly produced lactate (23.1 mM ± 1) (Fig. 5). Streptococcus
gordonii, the most abundant strain in the CHX treated 14-strain
biofilms, is considered a primary colonizer of the dental surface24
and produces L-lactate as primary metabolite. While it is less
aciduric than mutans streptococci25, it succeeded in dominating
the synthetic oral biofilm despite the significant decrease in pH
from 7 to pH 5.8 during the incubation experiment. High
concentrations of lactate in combination with a low pH (the pKa
of lactic acid/lactate being 3.86) are important determinants of
tooth demineralization and tooth decay and increase the risk for
dental caries. At the same time, the concentrations of the
pathobiont strains were not reduced (with the exception of S.
mutans). This outcome cannot be explained by the individual
Fig. 3 nMDS plot representing the β-diversity of the tongue deriving microbiota biofilm samples based on Bray Curtis dissimilarity
index. Samples deriving from different donors have a different color, circles are for CHX treated samples, while triangles symbolize non-
treated control samples. The number indicates the time of the sampling in hours.
Fig. 4 The bacterial composition of oral biofilms over the course of treatment. Relative abundance of the 20 most abundant OTUs for the
tongue derived microbiota biofilms every 24 h and before the next CHX treatment.
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tolerance to chlorhexidine as most strains exhibit similar or lower
MIC than other strains which relative abundance decreased
drastically (e.g., V. parvula). The higher survival rates of the
pathobiont strains could be explained by the biogeography of the
oral biofilm, where these strains normally inhabit the inner layers
of the biofilm and they are thus more protected26.
The bacterial community of the tongue microbiota biofilms was
also affected by CHX treatments. The most pronounced shift was
observed in the biofilms derived from donor 4 where there was a
continuous increase of the relative abundance of the genus
Fusobacterium over the course of the daily CHX treatments. The
increased dominance of Fusobacterium is significant because it is
considered a bridge organism between early and late colonizers in
oral biofilms facilitating biofilm maturation and attachment of
pathobionts. This genus is prevalent in periodontal plaque
samples27,28 and thus linked to periodontal disease. The observed
higher production of butyrate by the CHX exposed natural biofilm
is also indicative of higher Fusobacterium dominance23,29. Butyrate
is a bacterial metabolic by-product with detrimental effects for
oral health, triggering inflammation in gingival fibroblasts30 and
disrupting the gingival epithelial barrier31. With respect to the
other in vivo derived biofilms, we found the antiseptic treatment
to impact the biofilms in a dynamic and donor-dependent
manner, with composition and metabolic activity shifting after
every treatment. Despite the fact that non-treated mature biofilms
clustered together according to β-diversity, the community
composition of CHX treated biofilms was clearly dependent on
initial inoculum. Our results confirm previous observations where
inter-personal microbiome variability was described as one of the
main drivers in response to oral treatment32,33.
Overall our findings made evident that wide spectrum
antimicrobials cannot guarantee a shift to a healthy state. On
the contrary they can further perturb the commensal microbiome.
These findings are in accordance with recent in vivo study that
shows that CHX treatment although kept microbial load in lower
numbers than no treatment, did so by unselective targeting of the
oral microbiome which resulted in higher relative abundances of
several periodontitis related taxa (i.e., Fusobacterium)34. Moreover
antiseptics have been already shown to increase pathogenic
characteristics35, resistance to antiseptics36, and cytotoxicity to host
cells37. For this reason there is a clear need for alternative
approaches that do not indiscriminately target the oral micro-
biome but would specifically and selectively target pathogenic
strains38 (or their virulence—virulence therapy) and promote or re-
establish a healthy microbiome (pro-biotics and pre-biotics)39–41.
To conclude, we state that antiseptics are inadequate as sole
treatment of oral biofilms. We observed that short treatment with
0.12% CHX, a concentration commonly used in oral care products,
only temporarily decreased the viable cell concentration. Further-
more, our results suggest that initial microbiome composition
highly influenced the outcome of the antiseptic treatment with
disease associated characteristics increasing after treatment in
certain cases. Further in vivo experiments are required to elucidate
the clinical relevance of this study and the possible implications of
the extensive use of antimicrobials in oral care.
MATERIALS AND METHODS
Strains and culture
The synthetic community was assembled by 14 oral bacterial strains, eight
commensal (Streptococcus sanguinis LMG14657, Streptococcus salivarius
TOVE-R, Streptococcus gordonii ATCC 49818, Streptococcus mitis DSM 12643,
Streptococcus oralis (clinical isolate), Actinomyces naeslundii ATCC 51655,
Actinomyces viscosus DSM 43327 and Veillonella parvula DSM 2007) and six
pathobionts (Porphyromonas gingivalis ATCC 33277, Fusobacterium nucle-
atum ATCC10953, Aggregatibacter actinomycetemcomitans ATCC 43718,
Prevotella intermedia ATCC 25611, Streptococcus mutans ATCC 25175 and
Streptococcus sobrinus ATCC 33478). The strains were maintained on blood
agar No2 (Oxoid, Hampshire,UK) supplemented with hemin (5mg/mL)
(Sigma Aldrich, Belgium), menadione (1 mg/mL) (Sigma Aldrich, Belgium)
and 5% sterile horse blood or cultured in liquid medium in Brain Hearth
Infusion (BHI) (Roche, Belgium) broth under anaerobic (80% N2, 10% H2,
and 10% CO2) conditions.
BHI medium was used for the assembled synthetic community. This
medium is enriched with 2.5 g/L Mucin from porcine stomach type III
(Sigma, Diegem, Belgium), 1.0 g/L Yeast extract (Oxoid, Hampshire, UK),
0.1 g/L cysteine (Merck—Calbiochem), 2.0 g/L sodium bicarbonate (Sigma
Aldrich, Belgium), 0.25% glutamic acid (Merck—Calbiochem), 5.0 mg/L
hemin (Sigma Aldrich, Belgium), 1.0 mg/L menadione (Sigma Aldrich,
Belgium).
Minimum inhibitory concentration
The MIC of CHX for each individual strain was evaluated by absorbance.
More specifically, 107 cells/mL of each strain was inoculated in serial
dilutions of CHX and incubated for 24 h under anaerobic conditions.
Following OD600 was measured by microtiter plate reader (Tecan Infinite
M200 Pro; Tecan UK, Reading, UK).
Tongue microbiome sampling
The tongue microbiome samples originated from four individuals. The
individuals were in good systemic health and had not received antibiotics
over the previous 3 months. The donors were asked to refrain from food
Fig. 5 The effect of CHX treatment on the metabolic activity of the in vitro oral biofilms. The organic acid production or consumption by
the 14-strains (average of four replicates) and tongue-deriving microbiota biofilms in between the daily treatments with 0.12% CHX.
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intake or tongue/tooth brushing for at least 2 h before collection of the
tongue biofilm.
Tongue biofilm was sampled by scraping the tongue surface with a
disposable tongue scraper (Jordan, Norway) three times from back to front
of the tongue dorsum. The scrapped biofilm was suspended in 5mL of
reducing phosphate buffer (8.8 g/L K2HPO4, 6.8 g/L KH2PO4 and 1 g/L
C2H3O2SNa (Sigma Aldrich, Belgium)) and homogenized by pipetting
keeping individual samples separate. One milliliter of each sample was
used to inoculate a separate anaerobic penicillin bottle with 15mL BHI 2
medium. Samples were allowed to separately grow in planktonic
conditions for 48 h before used further to grow a biofilm.
Biofilm model
After the 14 strains had grown individually in BHI broth as described
above, the synthetic community was assembled by adding equal
concentrations of each strain in BHI 2 medium. Then they were allowed
to grow for 48 h under anaerobic (80% N2,10% H2, and 10% CO2)
conditions. Subsequently inoculum from the planktonic bioreactor was
used to grow biofilms on hydroxyapatite (HA) disks (0.5 inch diameter ×
0.04–0.06 inch thick, VWR, Belgium) that were placed in an active
attachment biofilm model42. Sample of the bioreactor was diluted 1:2 v/v
in fresh BHI 2 medium. Two milliliter of the new culture containing the
community were added in each well of a 24-well plate and incubated for
24 h at 37 °C in anaerobic conditions and shaking at 170 rpm. Twenty-fours
hours-biofilms were used for the following experiments.
The same procedure was followed with the donor samples that had
been previously grown in BHI 2 for 48 h.
Treatment
The biofilms were treated with CHX by placing the HA disks for 5 min in a
new 24-well plate with 0.12% CHX (Chlorohexidine digluconate, Sigma
Aldrich, Belgium). Non-treated biofilms underwent the same procedure in
sterile PBS (Phosphate Buffer Saline, Sigma Aldrich, Belgium). They were
subsequently washed twice with PBS and finally placed back in a new 24-
well plate with fresh BHI 2 medium. The biofilms were treated every 24 h
and samples were collected before and after treatment. Biofilms were
disrupted by Trypsin-EDTA 0.05% at 37 °C, 350 rpm for 45 min and then
further placed in a sonication bath (37 kHz sonication frequency) for
32min to disrupt the aggregates.
Flow cytometry
Samples of the disrupted biofilm were diluted in sterile PBS and stained
with the nucleic acid stain SYBR® Green I and Propidium Iodide that stains
permeabilized cells43. SYBR Green I (10,000× concentrate in DMSO,
Invitrogen) was diluted 100 times in 0.22 µm-filtered DMSO (IC Millex,
Merck, USA) and Propidium Iodide (20mM in dimethyl sulfoxide (DMSO),
Invitrogen, USA) was diluted 50 times. Samples were stained with 10 µL/
mL staining solution. Next, they were incubated in 37 °C for 13 min. All
samples were measured with a benchtop Accuri C6+ cytometer (BD
Biosciences, Belgium). The stability of the instrument was controlled daily
using CS&T RUO beads (BD Biosciences, Belgium) and checking for each
measurement the stability of FL1 over time. The blue laser (488 nm)was
used for the excitation of the stains. The filters for the (fixed gain)
photomultiplier detectors used during the measurements were 533 nm
with a bandpass of 30 nm for the green fluorescence (FL-1) and 670 nm
longpass filter for the red fluorescence (FL-3). The threshold was set on the
533/30 nm (FL-1) detector at the arbitrary unit of 500. FlTC-A ~ PerCP-A
density plots were used to draw gates for intact, damaged and dead cells
according to Supplementary Fig. 1.
DNA extraction and vitality qPCR of the 14-strain biofilms
The disrupted biofilms were treated with PMAxx Dye (Biotium, USA) before
further manipulation. DNA extraction was performed by means of bead
beating with a PowerLyzer instrument (Qiagen, Venlo, Netherlands) and
phenol/chloroform extraction. The surviving bacteria were quantified by
vitality qPCR using specific primers44,45. The qPCR measurements were
performed with a CFX96 Real-Time System (Bio-Rad, Temse, Belgium). In
short, Taqman 5′ nuclease assay PCR method was used for detection and
quantification of every one of the 14 strains using strain specific primers
and probes (Supplementary Table 1). Quantification was based on a
plasmid standard curve.
DNA extraction and amplicon sequencing of multispecies biofilms
DNA from the multi-species biofilms was extracted using the ZymoBIO-
MICS DNA Microprep Kit (Zymo Research, USA) according to the
manufacturer's instructions. 10µl genomic DNA extract was send out to
LGC genomics GmbH (Berlin, Germany) for library preparation and
sequencing on an Illumina Miseq platform with v3 chemistry with the
primers 341F (5′-CCT ACG GGN GGC WGC AG -3′) and 785Rmod (5′-GAC
TAC HVG GGT ATC TAA KCC-3′)46.
The average number of raw reads per sample was 45712. Read assembly
and cleanup was largely derived from the MiSeq SOP described by the
Schloss lab. In brief, mothur (v.1.40.3) was used to assemble reads into
contigs, perform alignment-based quality filtering (alignment to the
mothur-reconstructed SILVA SEED alignment, v. 123), remove chimeras,
assign taxonomy using a naïve Bayesian classifier47 and SILVA NR v132 and
cluster contigs into OTUs at 97% sequence similarity. All sequences that
were classified as Eukaryota, Archaea, Chloroplasts and Mitochondria were
removed. Also, if sequences could not be classified at all (even at (super)
Kingdom level) they were removed. After the above-mentioned filtering,
the average reads per sample were 27940. For each OTU representative
sequences were picked as the most abundant sequence within that OTU.
Metabolic activity
Organic acids in the samples were measured with 761 Compact Ion
Chromatograph (Metrohm, Switzerland) with a Metrosep Organic acids
250/7.8 column and a Metrosep Organic acids Guard/4.6 guard column.
The eluent consists of 1 mM H2SO4 at a flow rate of 0.8 mL/min. The
production of organic acids was calculated as the concentration detected
in the liquid that the biofilm was grown normalized for the organic acid
concentrations detected in sterile BHI 2 medium.
Data analysis/statistics
All statistical analysis was performed in R (v3.6.0). The OTU contingency
table was imported in R. OTUs with no more than one read in every sample
(singletons) were removed48. The average number of reads per sample
after removing singletons was 27866, while the total number of OTUs was
2350. The graphs representing the 20 most relative abundant genera were
generated using the phyloseq package49 in R (v3.6.0). The taxonomic
β-diversity was calculated based on Bray-Curtis dissimilarity index, using
the ordinate function of phyloseq package, and displayed in a non-metric
multidimensional scaling (nMDS) plot.
Ethics statement
The sampling of human tongue biofilm was approved by the the Medical
Ethical Committee of Ghent University with reference number
B670201629302. All participants gave their written informed consent prior
to their inclusion in the study.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
DATA AVAILABILITY
Sequences are available on the NCBI Sequence Read Archive (SRA) under accession
number PRJNA554992.
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